These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11502514)

  • 41. Increasing Helicobacter pylori clarithromycin resistance in Australia over 20 years.
    Schubert JP; Warner MS; Rayner CK; Roberts-Thomson IC; Mangoni AA; Costello S; Bryant RV
    Intern Med J; 2022 Sep; 52(9):1554-1560. PubMed ID: 34865299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increase in resistance rates of H. pylori isolates to metronidazole and tetracycline--comparison of three 3-year studies.
    Siavoshi F; Saniee P; Latifi-Navid S; Massarrat S; Sheykholeslami A
    Arch Iran Med; 2010 May; 13(3):177-87. PubMed ID: 20433221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial resistance in Helicobacter pylori isolates from children.
    Rerksuppaphol S; Hardikar W; Midolo PD; Ward P
    J Paediatr Child Health; 2003 Jul; 39(5):332-5. PubMed ID: 12887661
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999-2003.
    Bruce MG; Bruden DL; McMahon BJ; Hennessy TW; Reasonover A; Morris J; Hurlburt DA; Peters H; Sacco F; Martinez P; Swenson M; Berg DE; Parks D; Parkinson AJ
    Helicobacter; 2006 Dec; 11(6):581-8. PubMed ID: 17083381
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of previous eradication failure on antibiotic resistance of Helicobacter pylori: A retrospective study over 8 years in Beijing.
    Li SY; Li J; Dong XH; Teng GG; Zhang W; Cheng H; Gao W; Dai Y; Zhang XH; Wang WH
    Helicobacter; 2021 Aug; 26(4):e12804. PubMed ID: 33860967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan.
    Wu IT; Chuah SK; Lee CH; Liang CM; Lu LS; Kuo YH; Yen YH; Hu ML; Chou YP; Yang SC; Kuo CM; Kuo CH; Chien CC; Chiang YS; Chiou SS; Hu TH; Tai WC
    World J Gastroenterol; 2015 Oct; 21(37):10669-74. PubMed ID: 26457027
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibiotic resistance in Helicobacter pylori.
    Mollison LC; Stingemore N; Wake RA; Cullen DJ; McGechie DB
    Med J Aust; 2000 Nov; 173(10):521-3. PubMed ID: 11194734
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antimicrobial susceptibility of Helicobacter pylori strains isolated from children in Israel.
    Pastukh N; Peretz A; Brodsky D; Isakovich N; Azrad M; On A
    J Glob Antimicrob Resist; 2018 Mar; 12():175-178. PubMed ID: 29033302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibiotic resistance of
    Jiang Z; Qian X; Wang Z; Dong Y; Pan Y; Zhang Z; Wang S
    Front Cell Infect Microbiol; 2022; 12():970630. PubMed ID: 36159644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro activity of clarithromycin against intracellular Helicobacter pylori.
    Piccolomini R; Di Bonaventura G; Picciani C; Laterza F; Vecchiet J; Neri M
    Antimicrob Agents Chemother; 2001 May; 45(5):1568-71. PubMed ID: 11302831
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan.
    Chang WL; Sheu BS; Cheng HC; Yang YJ; Yang HB; Wu JJ
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1230-5. PubMed ID: 19476562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000.
    Wolle K; Leodolter A; Malfertheiner P; König W
    J Med Microbiol; 2002 Aug; 51(8):705-709. PubMed ID: 12171304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pylori.
    Rajinikanth PS; Balasubramaniam J; Mishra B
    Int J Pharm; 2007 Apr; 335(1-2):114-122. PubMed ID: 17141986
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rates of Antimicrobial Resistance in Helicobacter pylori Isolates From Clinical Trial Patients Across the US and Europe.
    Mégraud F; Graham DY; Howden CW; Trevino E; Weissfeld A; Hunt B; Smith N; Leifke E; Chey WD
    Am J Gastroenterol; 2023 Feb; 118(2):269-275. PubMed ID: 36191284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro activity of omeprazole in combination with several antimicrobial agents against clinical isolates of Helicobacter pylori.
    Alarcón T; Domingo D; Sánchez I; Díaz de Rojas F; López-Brea M
    Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):937-40. PubMed ID: 9031877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [In vitro antimicrobial susceptibility of Helicobacter pylori strains: isolation of strains resistant to clarithromycin].
    González C; García A; Daroch F; Kawaguchi F; Solar H; Rivera N; Vega E
    Rev Med Chil; 2001 Jun; 129(6):643-6. PubMed ID: 11510204
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands.
    Debets-Ossenkopp YJ; Herscheid AJ; Pot RG; Kuipers EJ; Kusters JG; Vandenbroucke-Grauls CM
    J Antimicrob Chemother; 1999 Apr; 43(4):511-5. PubMed ID: 10350380
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in Ningxia.
    Hu S; Zhou Y; Deng Y; Bo Y; Chen X; Yang W; Shi R; Zhao W; Hou Z; Hu J; Liu J; Zhang X; Yong H; Wang P; Li F; Qi H; Wang X; Jin L; Cui T; Yong H; Li X; Yang B; Yu Y; Ma B; Fu L; Wang X; Ma Z; Tang N; You Y; Guo J; Yu X; Yao L; Gao R; Li Y; Xin R; Liu J; Cao Z; Li H; Ma L; Ma S; Cao Y; Tang Y; Liu J; Hao Q; Li X; Li X; Mu R; Niu M; Su X; Gao H
    Helicobacter; 2023 Jun; 28(3):e12960. PubMed ID: 37042045
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Broad spectrum resistance in Helicobacter pylori isolated from gastric biopsies of patients with dyspepsia in Cameroon and efflux-mediated multiresistance detection in MDR isolates.
    Kouitcheu Mabeku LB; Eyoum Bille B; Tepap Zemnou C; Tali Nguefack LD; Leundji H
    BMC Infect Dis; 2019 Oct; 19(1):880. PubMed ID: 31640588
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro anti-Helicobacter pylori activity of BAS-118, a new benzamide derivative.
    Kobayashi I; Muraoka H; Hasegawa M; Saika T; Nishida M; Kawamura M; Ando R
    J Antimicrob Chemother; 2002 Jul; 50(1):129-32. PubMed ID: 12096019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.